News for Cogstate Limited (CGS.AX)

Published at

Feb 20, 2025 2:47 AM

by seekingalpha.com

mixed

mixed

Cogstate Limited (COGZF) Q2 2025 Earnings Call Transcript

Cogstate Limited (OTCQX:COGZF) Q2 2025 Earnings Conference Call February 19, 2025 5:00 PM ETCompany ParticipantsBrad O'Connor - Chief Executive...

COGZF CGS.AX AND.AX

Read more →
Published at

Oct 14, 2024 5:14 PM

by asiaone.com

positive

positive

Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer

Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer GlobeNewswire October 14, 2024 Melbourne, VIC, Australia; New Haven, CT, USA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Cogstate, a leading neuroscience technology company, today announced the appointment of Kaycee Sink, MD, MAS, as Chief Medical Officer. In...

CGS.AX

Read more →
Published at

Oct 14, 2024 5:14 PM

by globenewswire.com

positive

positive

Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer

Melbourne, VIC, Australia; New Haven, CT, USA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Cogstate, a leading neuroscience technology company, today announced the...

CGS.AX

Read more →
Published at

Aug 22, 2024 11:43 AM

by seekingalpha.com

positive

positive

Cogstate Limited (COGZF) Q4 2024 Earnings Call Transcript

Cogstate Limited (OTCQX:COGZF) Q4 2024 Earnings Conference Call August 21, 2024 6:30 PM ETCompany ParticipantsBrad O'Connor - Chief Executive OfficerDarren...

COGZF CGS.AX

Read more →
Published at

Aug 12, 2024 3:05 PM

by manilatimes.net

mixed

mixed

Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial

There was a clinically meaningful and persistent improvement depression measured by the key secondary endpoint of MADRS.[1] The primary endpoint of superiority to placebo in a cognitive 'attention composite' of three Cogstate computerized tests was not met with large improvements seen in both Xanamem and placebo groups. Xanamem was safe and well tolerated.

CGS.AX ACW.AX

Read more →
Published at

Jul 23, 2024 6:56 PM

by investing.com

positive

positive

THREAD AND COGSTATE PARTNER TO SUPPORT CNS RESEARCH VIA NEXT GENERATION ECOA TECHNOLOGY AND LEADING COGNITIVE TESTING SOLUTIONS By Investing.com

THREAD AND COGSTATE PARTNER TO SUPPORT CNS RESEARCH VIA NEXT GENERATION ECOA TECHNOLOGY AND LEADING COGNITIVE TESTING SOLUTIONS

COGZF CGS.AX

Read more →
Published at

Apr 22, 2024 4:16 PM

by investing.com

mixed

mixed

Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial By Investing.com

Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial

CGS.AX ACW.AX

Read more →
Published at

Mar 29, 2024 4:46 AM

by gurufocus.com

positive

positive

Half Year 2024 CogState Ltd Earnings Call Transcript

Feb 21, 2024 / 09:30PM GMTBrad O'Connor - Cogstate Limited - CEO Good morning, everyone. Thank you for joining today's investor update, which include a discussi

COGZF CGS.AX

Read more →
Published at

Nov 9, 2023 12:12 PM

by prweb.com

positive

positive

uMotif and Cogstate Power CNS Research, Combining Patient-Centric eCOA/ePRO Data Capture Platform with Market-Leading Cognitive Solutions

/PRNewswire-PRWeb/ -- uMotif – one of the clinical research technology market's fastest growing companies – announced today a partnership with cognitive...

CGS.AX

Read more →
Published at

Sep 26, 2023 2:51 PM

by prnewswire.com

positive

positive

Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update

/PRNewswire/ -- XanaMIA Phase 2b trial...

COGZF CGS.AX ACW.AX

Read more →
Published at

Jul 14, 2023 4:30 AM

by seekingalpha.com

positive

positive

S&P/ASX All Technology Index Boosted By Tech Turnaround

Following a poor 2022, the Information Technology sector has proven itself to be the outstanding performer in Australian equities in 2023.

CGS.AX

Read more →
Published at

May 10, 2023 5:57 PM

by stockhead.com.au

mixed

mixed

Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?

Telehealth, mental health and aged care stocks rallied on Wednesday following the Budget announcement which include billions for healthcare.

REG.AX ONE.AX LME.AX JHC.AX GLH.AX 1ST.AX RGS.AX PXSLY PXS.AX PBP.AX OCC.AX MEB.AX MDBIF IVX.AX IPDQF IPD.AX IMM.AX HSC.AX CGS.AX ATX.AX ARUXF ADR.AX ACR.AX VTG.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX PGC.AX PCK.AX EYE.AX CMP.AX CAN.AX CAJ.AX BXN.AX AMT.AX

Read more →
Published at

May 10, 2023 1:14 AM

by stockhead.com.au

mixed

mixed

Market Highlights: Wall Street sweat on debt ceiling, CPI; and 5 ASX small caps to watch today

The ASX is poised to open modestly lower on Wednesday as US indexes fell in New York. Paypal plunged 13% after cutting its margins forecast.

SWKS SPA.AX RBL.AX QRVO EXP.AX BRKBD.BA BRKBB.BA BRKB.BA AVGOP AVGO AAPL PAA.AX CGS.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Mar 5, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger

Colossal Biosciences’ plans to bring the Tasmanian tiger and woolly mammoth back to life, but now it’s also betting on the iconic dodo.

TD1.AX RGS.AX RAC.AX FFC.AX EZL.AX PYC.AX PAB.AX OPT.AX OPT MX1.AX CMP.AX CKDXF AMT.AX VTG.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX PXSLY PXS.AX PSQ.AX PNV.AX PGC.AX PBP.AX ONE.AX OCC.AX NYR.AX NC6.AX MVF.AX MEM.AX MEB.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMM.AX HCT.AX GTG.AX GSS.AX EYE.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX ATX.AX ARUXF AMDHF ADR.AX ACR.AX

Read more →
Published at

Feb 28, 2023 6:39 AM

by stockhead.com.au

mixed

mixed

ASX Large Caps: Energy, Mining lead broad rally, Harvey Norman slumps 8pc on profit miss

The ASX rose half a percent on the final trading day of February. Adbri (ASX:ABC) fell while Cogstate rose

MEZ.AX FMG.AX DOW.AX DEG.AX CGS.AX ADLDY ADBCF ABC.AX SYR.AX RRL.AX PNV.AX PLS.AX LSF.AX JBH.AX CMM.AX CHN.AX CALZF BRG.AX BGL.AX AMCR A1CR34.SA WBT.AX NXT.AX IVC.AX HLS.AX

Read more →
Published at

Feb 27, 2023 7:25 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

Where are they now? 5 years ago today these resources stocks were the future of our stockmarket; And Gregor Stronach says: It's buyback time.

TWD.AX TD1.AX RBR.AX MYX.AX LCT.AX HGO.AX G88.AX FRDSF DOW.AX BMO.AX ARV.AX 4DS.AX XTE.AX WCG.AX SVY.AX SMX.AX SLX.AX SIX.AX SDG.AX OLI.AX NWM.AX MCT.AX LSA.AX LME.AX KEY.AX ICE.AX GTG.AX GLV.AX EYE.AX EGY.AX CGS.AX BBX.AX AVH.AX AUK.AX AQX.AX WBE.AX ROG.AX GTI.AX

Read more →
Published at

Feb 27, 2023 7:28 AM

by stockhead.com.au

mixed

mixed

CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal

The ASX has fallen 1.1% today after Wall Street got data-spooked on Friday, Aussie coal is heading to China and 4DS Memory climbed 39%.

TXMD TD1.AX SMX.AX RBR.AX LCT.AX HGO.AX G88.AX DOW.AX BMO.AX AVH.AX ARV.AX XTE.AX WFL.AX WCG.AX TWD.AX SVY.AX SLX.AX SIX.AX SDG.AX OLI.AX NWM.AX MYX.AX MCT.AX LSA.AX LME.AX KEY.AX ICE.AX GTG.AX GLV.AX FRDSF EYE.AX EGY.AX CGS.AX BBX.AX AUK.AX AQX.AX 4DS.AX WBE.AX ROG.AX GTI.AX 1ST.AX

Read more →
Published at

Feb 27, 2023 3:48 AM

by stockhead.com.au

mixed

mixed

ASX Small Caps Lunch Wrap: Who needs a few lessons on how to run their socials this morning?

In China, Hong Kong’s Hang Seng has dipped 0.21% in early trade, while Shanghai’s flatter than an illegally-fished flounder.

YPB.AX TD1.AX SMX.AX SLX.AX SDG.AX NEU.AX GTG.AX GLV.AX CAV.AX WCG.AX WBE.AX ROG.AX OLI.AX KEY.AX FRDSF AUK.AX AQX.AX AMD.AX AKN.AX 4DS.AX XTE.AX SI6.AX RFX.AX REFXF MCT.AX GTI.AX FGL.AX DOW.AX CGS.AX BWNAF AVH.AX APXYY APX.AX APT.AX APPEF ADV.AX

Read more →
Published at

Feb 26, 2023 8:10 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

Dementia is the new heart disease - these ASX stocks are in the fight, cleaning up on ex-div CBA, and is the gig economy growing again?

XF1.AX TSI.AX SFX.AX PXXXF OAU.AX NWM.AX NCZ.AX CGS.AX BVS.AX ZEU.AX VVA.AX TSL.AX TFL.AX TD1.AX SZHFF SSL.AX RBR.AX PVS.AX MLS.AX MLG.AX MFB.AX LCL.AX KNM.AX KNEOF KEY.AX GLV.AX GGX.AX EOFBF EOF.AX DTR.AX CXZ.AX CLT.AX CAV.AX BMO.AX 8VI.AX 8IH.AX 2768.T WBT.AX TTB.AX STK.AX SIX.AX RMY.AX RLG.AX RED.AX OBL.AX MOB.AX MEB.AX MEA.AX MDBIF KSC.AX ING.AX ICG.AX GTN.AX GPR.AX FYI.AX ERG.AX CVW.AX CSX.AX CL8.AX BUGLF BLG.AX BCK.AX AWC.AX ATU.AX ARV.AX AHQDB.AX AHQ.AX

Read more →